Most organisms, including humans, have developed an intrinsic system of circadian oscillators, allowing the anticipation of events related to the rotation of Earth around its own axis. The mammalian circadian timing system orchestrates nearly all aspects of physiology and behavior. Together with systemic signals, emanating from the central clock that resides in the hypothalamus, peripheral oscillators orchestrate tissue-specific fluctuations in gene expression, protein synthesis, and posttranslational modifications, driving overt rhythms in physiology and behavior. There is increasing evidence on the essential roles of the peripheral oscillators, operative in metabolically active organs in the regulation of body glucose homeostasis. Here, we review some recent findings on the molecular and cellular makeup of the circadian timing system and its implications in the temporal coordination of metabolism in health and disease. (Endocrinology 158: 1074(Endocrinology 158: -1084(Endocrinology 158: , 2017 
C ircadian oscillations of biological processes have been described in most light-sensitive organisms ranging from photosynthetic bacteria to humans. This anticipatory mechanism has developed to adapt to geophysical time changes due to the rotation of Earth around its own axis. In mammals, circadian control of physiology and behavior is driven by a master pacemaker, located in the bilateral suprachiasmatic nuclei (SCN) of the hypothalamus. Rhythmicity in the SCN is entrained by external Zeitgeber cues, such as daily changes in light intensity, and further transmitted to secondary, or slave oscillators, operative in peripheral organs (1) (2) (3) . Importantly, these oscillations persist also in constant darkness and cell-autonomous self-sustained circadian oscillators are functional in virtually all cells of the body (4) . Cellular circadian oscillators exhibit a similar molecular organization and are based on interconnected feedback loops of transcription and translation of key core clock components, which comprise BMAL1, CLOCK, PER1-3, CRY1-2, and the nuclear receptors REV-ERBs and RORs (3) . Beyond the transcriptiontranslation feedback loop of core clock components, posttranslational events such as protein phosphorylation, acetylation, O-GlcNAcylation, and degradation, as well as chromatin modification, contribute critically to the generation of daily oscillations of the core clock machinery (3, 5) . This molecular circuitry persists despite large variations of cellular transcription levels (6) , with redox oscillations being operative in the total absence of transcription (7, 8) .
The essential purpose of the circadian clock is to enable the temporal coordination of key metabolic processes with the geophysical time, in anticipation of rest-activity and feeding-fasting behavior. Circadian regulation ensures the proper temporal orchestration of metabolic processes upon physiological conditions, whereas circadian misalignment has been associated with the increased risk of metabolic disruptions, according to recent studies conducted in rodent models and in humans (9) (10) (11) (12) (13) (14) .
Maintaining blood glucose homeostasis represents one of the fundamental challenges in the regulation of body metabolism. There is increasing evidence suggesting that the circadian timing system plays an essential role in the regulation of glucose levels in rodents and in humans, which is mediated through a complex interplay between central and peripheral pathways ( Fig. 1) (10, 15, 16) . Strikingly, insulin secretion as well as insulin-independent glucose uptake are time-dependent and require an intact SCN (17, 18) . Furthermore, most of the clock-deficient mouse models exhibit hyperglycemia, compromised glucose tolerance, hypoinsulinemia, and increased insulin sensitivity (19) (20) (21) (22) (23) (24) . Of note, perturbations of glucose-stimulated insulin secretion were even more pronounced in Pdx1CreBmal1 knockout (KO) mice carrying a b-cell-specific Bmal1 KO, which develop features of overt diabetes mellitus already at the age of 2 months (20, 25) , whereas liver-specific Bmal1 KO mice exhibit increased glucose tolerance (24) . Furthermore, whereas whole-body Bmal1 KO mice have a tendency for increased fat mass and dyslipidemia, adipocyte-specific Bmal1 KO mice develop obesity (26) . A plausible mechanism, which may account for such tissue-specific effects of core clock disruption on the regulation of metabolism, has been recently suggested by Perelis et al. (27) . This study implies that the BMAL1-CLOCK dimer binds different enhancer and promoter elements within the genome of mouse islet and liver cells, possibly determined by cooperative binding with tissuespecific transcription factors.
Here, we review some of the recent studies on the regulation of glucose homeostasis by peripheral circadian clocks (Fig. 1) . Temporal orchestration of glucose metabolism by peripheral oscillators through organ-specific transcriptional regulation, as well as regulation of protein and lipid biosynthesis, or hormone and cytokine secretion under physiological conditions, will be discussed. Implication of peripheral circadian clock perturbations in the development of metabolic diseases in rodent models and in humans will be highlighted.
Liver Clocks
Liver plays a central role in mammalian metabolism, in part through the regulation of glucose homeostasis (28) . Glucose is entering hepatocytes via the BMAL1-regulated glucose transporter GLUT2 (24) . Once in the liver, glucose is transformed into glucose-6-phosphate by the rhythmically expressed enzyme glucokinase (29) and can then be used for glycogen synthesis, in part through the rhythmic regulation of glycogen synthase 2 by CLOCK (30) . Inversely, glycogen breakdown by glycogen phosphorylase was also described to be rhythmic (31) and under control of the molecular clock (32) , explaining why rhythmic glycogen synthesis and breakdown is disrupted in ClockD19 mutant mice (30) . Alternatively, glucose-6-phosphate can be used for energy production through the rhythmic activity of the mitochondrial tricarboxylic acid cycle (33) , or return in form of glucose after dephosphorylation by the rhythmic glucose-6-phosphatase (34) . While the positive limb of the core clock, composed of BMAL1 and CLOCK, plays an important role in this process, a key function of the REV-ERBa and REV-ERBb components, associated with histone deacetylase 3 (HDAC3) (35) , has been recently described in glucose metabolism and insulin sensitivity, mainly through the regulation of liver lipid metabolism (36, 37) .
In addition to its direct action on the regulation of different genes/proteins, the circadian clock also timely regulates several aspects of physiological signaling involved in these processes. For example, the critical impact of insulin signaling on liver glucose metabolism is decreased by mutations of both Bmal1 (38) and Per2 (39), whereas glucagon signaling is compromised in Cry deficient mice (23) . In parallel, the action of glucocorticoids on liver glucose management (40) is timely controlled through the SCN in a light-dependent manner (41) but also through the direct action of CRY on the rhythmic activity of the glucocorticoid receptor (42) . Finally, the sympathetic nervous system plays a role in maintaining glucose homeostasis (43) , and it demonstrates a rhythmic activity (44) that coordinates rhythmic glucose metabolism in the liver (45, 46) . This result confirms that the circadian clock regulates liver glucose metabolism at both the local level through the temporal regulation of key enzymes of liver metabolism, but also at the systemic level by the timely control of physiological signals coming from other tissues. Of note, hepatokines play an important role in regulating glucose homeostasis, comprising FGF21 and the sex hormone-binding globulin, which are both secreted in a circadian manner ( Fig. 1 ) (47-50).
Endocrine Pancreas and Enteroendocrine Cellular Clocks
In rodents, circadian oscillations of the endocrine pancreas have been recently demonstrated to play an essential role in driving gene transcription and hormone secretion (20, 25, 27, 51) . Essentially, a recent study by Perelis et al. (27) provided convincing evidence for high-amplitude circadian rhythms of insulin secretion by isolated pancreatic islets, highlighting the role of the cell-autonomous islet oscillator in the regulation of its secretory function.
In line with these findings, gene expression related to the insulin secretory pathway was severely compromised in mice bearing a disrupted b-cell clock (b-cell-specific Bmal1 KO) (27) . Importantly, by developing an inducible b-cell-specific Bmal1 KO model, which compromises the b-cell clock at an adult age, the authors provide compelling evidence that disruption of b-cell clock function during adulthood results in the development of overt diabetes mellitus, implying that the observed phenotype cannot be attributed to developmental defects during islet differentiation (27) . Taken together, the above studies imply that the b-cell clock coordinates the release of insulin and b-cell gene transcription, and that clock perturbations might be linked to defects in islet function and type 2 diabetes (T2D) development.
The pancreatic islet is a tight threedimensional structure, which comprises distinct endocrine cell types, with a and b cells representing about 10% to 15% and 80%, respectively, in rodent islets. Beyond the primordial role of b-cell dysfunction in the development of T2D, it has been proposed decades ago that alterations in a-cell function and resulting hyperglucagonemia are important components of the metabolic aberrations associated with T2D (52) . Following this bihormonal hypothesis with regard to the etiology of T2D, studies of a-cell physiology and regulation of glucagon secretion have caught more and more attention, particularly with respect to the potential treatment of T2D (53) (54) (55) (56) (57) . However, until recently, few reports about the circadian physiology of a cells were available (58) , mainly due to the difficulty to recognize and isolate these cells. The development of highly specific fluorescent islet cell reporters has opened new horizons for studying a-and b-cell functions separately (59) (60) (61) . Taking advantage of these reporter mouse models for a-and b-cell-specific labeling, we have recently conducted the first parallel assessment of a-and b-cell circadian properties in vivo and in vitro (62) . Surprisingly, these experiments revealed that a-and b-cell clocks harbor different circadian properties in vivo and in vitro, and in response to physiologically relevant stimuli such as epinephrine. The distinct circadian properties of a-and b-cellular clocks were observed at population and at Circadian control of glucose metabolism implies the combination of central and peripheral regulators. The SCN, being a principal sensor of extrinsic cues, coordinates the function of peripheral oscillators via neuroendocrine signals and feeding behavior. Diurnal utilization of ingested glucose in metabolic tissues relies on the interplay between hormones secreted by the endocrine pancreas, with insulin decreasing (-) blood glucose and glucagon increasing (+) blood glucose levels, and incretins regulating islet hormone secretion, with glucagonlike peptide-1 derived from intestinal L cells being the principal one. Circadian oscillations of both islet hormone secretion and transcriptome changes in isolated islet cells suggest that islet cell clocks gate the response of the endocrine pancreas to blood glucose in a cell-autonomous manner. Molecular clocks in metabolic tissues coordinate intracellular glucose metabolism in a tissue-specific manner via concordant circadian changes in the transcriptome, proteome, and lipidome as well as in enzyme kinetics. The reciprocal circadian release of hepatokines, myokines, and adipokines by respective metabolic tissues represents a feedback loop of glucose homeostasis, further modulating central and peripheral regulators.
single-cell levels. Importantly, studies of glucagon and insulin secretion in separated a-and b-cell cultures revealed oscillatory profiles for both hormones, further suggesting that cell-autonomous a-and b-cellular clocks are likely to contribute importantly to the orchestration of temporal secretion patterns of glucagon and insulin (62) (62) . Collectively, these findings illustrate the interplay between acute control mechanisms of insulin or glucagon secretion, driven mainly by feeding-fasting conditions, which are reflected in fast changing blood glucose levels, and "hardwired" anticipatory mechanisms driven by cellautonomous islet clocks, which are coordinating diurnal profiles of insulin and glucagon secretion that govern glucose homeostasis.
The digestive, absorptive, and proliferative activities of the gut are also rhythmic, thereby tying nutrient ingestion closer to the metabolic clock (63, 64) . Beyond modulating circadian patterns of islet hormone secretion, peripheral clocks operative in intestinal enteroendocrine L cells have been recently demonstrated to play a role in the regulation of glucagonlike peptide-1 (GLP-1) secretion (65, 66) . GLP-1, an incretin hormone, is produced predominantly by L cells and impacts on glucose metabolism and energy homeostasis through regulation of islet hormone secretion (Fig. 1) . Furthermore, it inhibits gastrointestinal motility and food intake (67) . Recently, an elegant study revealed a diurnal rhythm in GLP-1 secretion in response to oral glucose, which was abolished under constant light conditions, mirroring the pattern of insulin secretion (65) . The circadian pattern of GLP-1 secretion is likely regulated by cell-autonomous clocks operative in L cells, as suggested by in vitro studies on GLUTag cells (65) . These findings imply that GLP-1 may represent an important component of the peripheral metabolic clock in rodents and in humans, and alterations in the GLP-1 secretory response might result from circadian perturbations associated with the development of metabolic diseases (66) . Thus, temporal coordination between insulin, glucagon, and GLP-1 secretion by the circadian clock is likely to be of critical importance for maintaining glucose homeostasis (Fig. 1) . Further exposure of the circadian coordination of hormone secretion by cellular clocks operative in pancreatic islets and in L cells, respectively, and their dysregulation observed under metabolic diseases might shed new light on our understanding of the etiology of metabolic diseases including T2D.
Skeletal Muscle and Adipose Clocks
Skeletal muscle is the largest insulin sensitive organ in the body, playing a major role in whole body substrate homeostasis in the postprandial state. During the last decade, skeletal muscle was also identified as a secretory organ, producing and releasing myokines [e.g., interleukin (IL)-6, IL-8], which have direct effects on the muscle itself, and endocrine effects on distant organs (68, 69) . In rodents, about 7% of the skeletal muscle transcriptome was expressed in a circadian manner (70) , with clock disruption leading to skeletal muscle pathologies in Bmal1 KO mice (71) . MyoD, a master regulator of myogenesis, is a direct target of CLOCK and BMAL1 (71) . Moreover, disruption in myofilament organization was detected in Bmal1 KO, and in ClockΔ19 mice, suggesting a direct link between core clock and skeletal muscle gene expression and function in rodents. Importantly, a number of functional skeletal muscle genes, involved in the regulation of glucose metabolism, exhibited diurnal rhythmic profiles, which were disrupted in mice with a muscle-specific Bmal1 KO (72). Skeletal muscles from mice bearing such a muscle-specific clock disruption showed impaired insulin-stimulated glucose uptake, mediated by reduced protein levels of GLUT4 (insulin-regulated glucose transporter) and TBC1D1 (Rab-GTPase involved in GLUT4 translocation to the plasma membrane) (73, 74) . Moreover, a metabolome analysis of muscle-specific Bmal1 KO mice revealed a reduction in glucose oxidation and diversion of glycolytic intermediates to alternative metabolic pathways, due to the reduced activity of pyruvate dehydrogenase (73) . Defects in glucose metabolism induced by the muscle-specific deletion of Bmal1 imply that a major physiological role of the skeletal muscle clock is to prepare for the transition from the fasting to feeding phase, when glucose becomes the predominant fuel. Additionally, an important mechanism in the coordination of muscle insulin sensitivity by the local circadian clock through the epigenomic modifier HDAC3 has been recently uncovered (75) . The results imply that the skeletal muscle-specific depletion of HDAC3 causes severe insulin resistance. At the same time, HDAC3 depletion enhances muscle endurance, with both phenotypes being attributed to lower glucose utilization and higher lipid oxidation levels in the HDAC3 depleted muscle. Together with additional recent studies, this work supports the important message that physical exercise performed at a certain time window during the day could be an important mediator of improved systemic glucose metabolism (75, 76) . Taken together, recent circadian studies of transcriptional, epigenomic, metabolic, and functional regulation leave little doubt regarding the fundamental role of the endogenous skeletal muscle clock in the control of muscle insulin sensitivity and glucose uptake (72) (73) (74) (77) (78) (79) (80) (81) (82) .
Beyond these transcriptional and metabolic studies, recent work by Thurley et al. (83) provides an integrative analysis of the circadian orchestration of metabolic pathways. This work further underlies that a fundamental role of the circadian system is the temporal separation of metabolic processes, whose simultaneous occurrence would be energetically counterproductive. Indeed, peak activities of rhythmic key metabolic enzymes (e.g., linear chains and branching points) were temporally separated in a coordinated manner, allowing for the optimization of a rhythmic pathway flux, as it was demonstrated by the combination of a theoretical model based on transcriptomic studies, with rhythmic enzymatic activities measured in skeletal muscle in vivo (83) .
Adipose tissue represents another essential player in regulating glucose homeostasis, being a major site of glucose utilization. It exerts a wide variety of key metabolic functions comprising energy storage, thermogenesis, and endocrine activity (adipokine secretion), with adipose cellular clocks impacting critically on most of these functions ( Fig. 1) (84-87) . Recent findings on the circadian regulation of adipose tissue and its role in glucose homeostasis through the reciprocal interaction of adipose rhythms and various secreted factors (insulin, glucocorticoids, leptin, adiponektin) are summarized in detail in an extensive up-to-date review by Kiehn et al. (14) .
Impact of Human Peripheral Clocks on Glucose Metabolism
The circadian system plays an important role in coordinating glucose metabolism in human subjects. Indeed, patients with circadian misalignments suffer from profound perturbations of plasma glucose and insulin levels (9, 11, 88) , and genetic linkage analyses revealed the association of CRY2 and PER2 variants with blood glucose levels (89, 90) .
Human molecular clock studies-employing classical biochemistry and molecular biology analyses of a series of blood, urine, or tissue samples obtained across a time span of 24 hours-provided important information on hormone and metabolite oscillatory profiles (91-94). The considerable limitations of these approaches are, however, related to the low temporal resolution, and impossibility of repetitive sampling from most human tissues. The recent development of state-of-the-art methodologies based on bioluminescent reporters driven by circadian promoters (4), allows for the recording of molecular oscillatory profiles in human tissue explants and/or primary cultures with high precision and temporal resolution. Synchronization of cellular clocks in vitro can be conducted by either a plethora of compounds (95) or by temperature cycles (96) , offering the possibility to assess synchronization properties of human peripheral clocks by physiologically relevant stimuli. Pioneering molecular studies on human peripheral clocks were conducted by Steven Brown et al. (97) (98) (99) in primary human skin fibroblasts, synchronized in vitro. Later on, this approach was adapted for studying cell-autonomous clocks operative in different human tissues, and their transcriptional and functional outputs (27, (100) (101) (102) (103) .
Our own recent studies revealed that human pancreatic islets synchronized in vitro exhibit highamplitude, self-sustained circadian oscillations (101) . These cellular clocks were characterized at population level by circadian bioluminescence recording and at single-islet and single-cell levels by high-resolution bioluminescence-fluorescence time-lapse microscopy. Furthermore, circadian bioluminescence reporter assays with Bmal1-luciferase and Per2-luciferase lentivectors revealed that primary human skeletal myotubes synchronized in vitro exhibit a self-sustained circadian rhythm, which was further confirmed by endogenous core clock transcript expression (102, 104) . Importantly, basal secretion of insulin by human islet cells, and secretion of IL-6, IL-8, and MCP-1 by human primary skeletal myotubes, followed an oscillatory profile, implying a role of these cellular oscillators in the orchestration of human islet and skeletal muscle endocrine function (Fig. 2) (102, 103) . The development of small interfering RNA-mediated clock disruption approaches in human primary cell cultures allows further assessment of the relevance of clock function for the regulation of tissue physiology and gene transcription. Indeed, the oscillatory profile of insulin, secreted by human islet cells, was strongly disrupted in the absence of a functional clock (Fig. 2 , left panel), with glucose-stimulated insulin secretion being compromised as well (103) . Similarly, basal secretion of IL-6 (Fig. 2, right panel) and additional myokines, as assessed by myokine multiplex analyses, was strongly dysregulated upon clock disruption (102) . The observed perturbations of insulin or myokine secretion upon islet or skeletal muscle clock disruption were in line with the diminished levels of key transcripts involved in the granule exocytosis process in these organs, as measured by RNA sequencing in samples with intact or disrupted clocks [(103), L. Perrin and C. Dibner, unpublished results] .
In view of the correlation between in vitro assessed oscillator properties and circadian phenotypes in vivo, studying human peripheral clock inputs and outputs in metabolic tissues and primary cells, are of highest and immediate clinical relevance.
Conclusions and Perspectives
Genome-wide transcriptome profiling studies indicate that the temporal orchestration of glucose metabolism is a major purpose of circadian clocks in peripheral metabolically active organs (70, 71, 86, (105) (106) (107) (108) (109) . This conjecture is further supported by emerging work employing proteomics, metabolomics and lipidomics approaches in rodents and humans, in which a large number of metabolites were found to oscillate in tissues, plasma, saliva, and urine (33, 91, 92, 94, 110-115 ). Taken together, recent transcriptome-, proteome-and metabolome-wide measurements have revealed a complex role of circadian rhythms in the regulation of glucose homeostasis. Despite a few pioneering studies (83, (116) (117) (118) , an additional effort should be put on unraveling circadian posttranslational changes (circadian acetylome, phosphorylome, etc.) and their impact on the activity of key metabolic enzymes. Furthermore, information about the circadian lipidome, metabolome, and hormone and cytokine secretion around the clock by peripheral organs are still scarce.
In spite of extensive studies in the field, underlying the key role of cell-autonomous self-sustained peripheral oscillators in the regulation of metabolic organ function, the coordination of distinct peripheral clocks in regulating body glucose homeostasis stays a complex puzzle yet to be unraveled. An essential and largely unexplored question remains to dissect effects driven by the central clock, feeding or other major synchronizers, from cellautonomous actions of each peripheral clock. The latter will be defined by a specific subset of surface receptors, glucose transporters, and proteins related to glucose metabolism, specific for each cell type. The key for unraveling this complex interaction will be to compare the results of circadian experiments conducted in vivo with experiments conducted in vitro, using isolated primary cells synchronized by physiologically relevant stimuli, which will vary for each organ/cell type (Fig. 2) . Because core clock genes also perform clock-unrelated functions, explaining the distinct phenotypes observed in different genetic mouse models for clock deficiency, studies in human metabolic organ explants upon clock disruption mediated by knockdown of core clock genes should be conducted. Comparing the results obtained in these models to one another, and to already available data from CLOCK-depleted cells (depicted at Fig. 2) , will allow distinguishing of clock-related and unrelated effects of core clock gene disruption on the respective transcriptional and functional regulation of each organ.
Numerous epidemiological studies imply that modern lifestyle, associated with circadian misalignments due to acute "jetlag" related to time zone changes or shifted work schedules, leading to a chronic circadian phase shift or "social jetlag," is associated with a number of pathologies, including metabolic diseases and cancer (9, 14, 88, 100, (119) (120) (121) (122) (123) (124) . If future translational studies in humans confirm that obesity and T2D are indeed associated with circadian clock perturbations, as has been demonstrated in rodent models, they will open new avenues for the treatment of these diseases. In this context, clock modulators, capable of reversing circadian oscillator perturbations by targeting either the negative or positive limb of the clock (27, (125) (126) (127) (128) , hereby represent future therapeutic targets for the treatment of metabolic disorders.
